New Eu2P PhD research work published

07 December 2016

Congratulations to Josep Pané who has published an article in Drug Safety: "Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines".
Findings particularly highlight the need of all stakeholders to develop a more proactive medical device safety evaluation process including real-world data to develop a risk assessment model!
Article available at

New Eu2P Master research project work published

Congratulations to Hager Ali Saleh who has published an article in the European Journal of Pharmaceutical and Medical Research: "Knowledge, Attitude and Practice of Health Professionals towards Adverse Drug Reactions Reporting": The research leading to the publication results has been performed during Hager's Eu2P Master research project.
Findings particularly highlight sources of ADR reporting improvements by healthcare professionals!
Article available at

Short Courses in pharmacovigilance and pharmacoepidemiology

Eu2P has recently launched a new Short Course offer to provide healthcare professionals with bite-sized courses to cope with very specific training needs and limited study time, any time online.
With Short Courses, you can build a highly personalised training programme and get certified!

Discover Eu2P Short Courses

Pharmacoeconomic‬ evaluation study prize

March 23th, 2016

Congratulations to Omneya Hassanain and Hammed Balogun who won the Eu2P expert jury prize for their pharmacoeconomic‬ evaluation study proposal: "Cost-effectiveness of pharmacogenetics testing before LABA in pediatric patients with asthma".

This study proposal was conducted under the assignment running over the different parts of the Master &s Certificate course module Principles of pharmacoeconomics and valuation of health states and presented online during the live meeting session on March 23th.






Learn from
world-class experts

Eu2P training programmes have been designed by a unique consortium of Universities, Regulatory Agencies and Pharmaceutical Companies.
This unique network has brought and invited the best experts from world industry, CROs, health authorities, professional societies and media to widen understanding, emphasize cultural specificities and therefore meet the job market needs.

Eu2P Partners

Study online
at your own pace

Eu2P has designed flexible modular programmes to ease access and study progression for people with limited time availabilities such as healthcare professionals.

Healthcare Professionals' guide

All Eu2P courses are delivered online so that students can access anytime from anywhere to learning contents and activities!

Eu2P eLearning

Get valuable and
recognized awards

Eu2P programmes delivers Master, PhD and Certificate diplomas that are jointly awarded by Eu2P academic partners and recognized by all Eu2P regulatory and industrial partners!

Certificates  Master  PhD

Eu2P also delivers Short Courses Certificates Of Achievement to demonstrate your Continuing Education progress.

Short Courses


They trust Eu2P

Companies offers


Former students' words...


  • Excellent programme! Incomparable opportunity to learn from leading experts in the area.

    Andrius Bacevicius
    • Andrius Bacevicius
    • Clinical Development Physician
  • For students and professionals who want to build a career in Pharmacovigilance and Pharmacoepidemiology.

    Manoa Razafimanantsoa
    • Manoa Razafimanantsoa
    • Drug Safety Associate
  • I highly recommend Eu2P because of the well balanced mix of various perspectives that you can rarely find in other programmes.

    Alexandra Barbulescu-Pacurariu
    • Alexandra Barbulescu-Pacurariu
    • Pharmacovigilance Assessor

More testimonials


Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners